Comment on this story

0 Comments on this story



Post comments

Email to a friend




Send email

Related Jobs

FDA 'tackles conflict of interest in advisory panels'

05 Aug 2008

Regulatory Affairs

The US Food and Drug Administration (FDA) is implementing reforms to the way its advisory committees work in an attempt to prevent cases of conflict of interest.

If a committee member is the principal investigator in a trial for a product about which the committee is to provide advice, then that person is not permitted to participate in the meeting, PharmaTimes reports.

Furthermore, it says if an individual - or their spouse or child - has potentially conflicting financial interests valuing more than $50,000 (£26,000) related to the product being discussed, they would likewise be barred from involvement in the meeting.

The FDA has said its new rules on conflict of interest are "more stringent than the legal requirements recently put in place by Congress", the website adds.

Meanwhile, the FDA has recently launched a two-year fellowship programme aimed at attracting scientists, engineers and health professionals to the agency.

It says the scheme will provide participants with "advanced training in the scientific analysis involved in the safety and regulatory decisions unique to the agency's mission".


Bookmark and Share

0 comments on this story